Bio Protocol
BIO
Bio Protocol BasicReport a Data Error
Bio Protocol Info
Bio Protocol Team
IndividualsBio Protocol Intro
BIO Protocol is a decentralized platform aimed at revolutionizing the funding and commercialization of biotechnology and decentralized science (DeSci). By allowing global participation, it enables patients, scientists, and investors to collaboratively fund, build, and own tokenized biotech projects and intellectual property (IP). This creates new opportunities for funding and accelerates the progress of life science innovations that have traditionally struggled due to complex funding processes, resource gaps, and fragmented IP ownership.
The protocol addresses key challenges in the biotech space, such as lengthy grant application processes and the "Valley of Death," where promising early-stage discoveries fail to reach commercialization. BIO Protocol leverages decentralized funding, capital efficiency, and shared IP ownership to reduce risks and costs, allowing a more inclusive and global approach to scientific advancement. It also provides liquidity to traditionally illiquid biotech assets, helping bridge the gap between innovative research and market-ready solutions.
At the heart of BIO Protocol is the BIO token, which enables governance and gives holders access to exclusive funding rounds and tokenized IP. The token also facilitates the coordination and support of BioDAOs, ensuring that participants can contribute and benefit from the growth of the ecosystem. BIO Protocol is transforming how biotech research is funded, developed, and shared, fostering a more open, efficient, and innovative environment for the entire industry.
Bio Protocol Unlock & AllocationReport a Data Error
Q&A about Bio Protocol Tokenomics
Explore the tokenomics of Bio Protocol (BIO) and review the project details below.
What is the allocation & supply schedule for Bio Protocol (BIO)?
Total Supply: At Genesis, the total supply will be 3,320,000,000 BIO tokens.
Max Supply: There is no fixed cap on the supply. Future BIO tokens may be minted to support protocol or network growth, and this will be decided through BIO governance. A new token contract may be deployed to replace the existing BIO token if necessary.
Initial Distribution of BIO Tokens
- Community: 56% (1,859,200,000 BIO)
- Community Auction: 20% (664,000,000 BIO)
- Vesting Schedule: 50% will be immediately liquid, and 50% will be unlocked linearly over 1 year.
- Community Airdrop: 6% (199,200,000 BIO)
- Vesting Schedule: 1-year cliff, followed by a 6-year vesting period.
- Ecosystem Incentives: 25% (830,000,000 BIO)
- Vesting Schedule: No vesting, tokens are immediately available.
- Molecule Ecosystem Fund: 5% (166,000,000 BIO)
- Vesting Schedule: 4-year vesting period.
- Investors: 13.6% (451,520,000 BIO)
- Vesting Schedule: 1-year cliff, followed by a 4-year vesting period.
- Core Contributors: 21.2% (703,840,000 BIO)
- Vesting Schedule: 1-year cliff, followed by a 6-year vesting period.
- Molecule Ecosystem Fund: 5% (166,000,000 BIO)
- Vesting Schedule: 4-year vesting period.
- Advisors: 4.2% (139,440,000 BIO)
- Vesting Schedule: 1-year cliff, followed by a 6-year vesting period.
Circulating Supply Distribution
As BIO tokens are gradually unlocked according to the above vesting schedules, the circulating supply of BIO will increase over time. It is expected that the circulating supply will rise steadily in the first three years, reflecting the progressive unlocking of tokens.
Inflation Mechanism
The inflation of BIO tokens will be linked to the growth of the BioDAO network. The specific inflation rate is yet to be determined, but it will be adjusted based on the expansion of the network and the addition of new BioDAOs.
Bio Protocol Token Allocation
People also watchReport a Data Error
Bio Protocol Price Live DataReport a Data Error
BIO Protocol is a decentralized platform aimed at revolutionizing the funding and commercialization of biotechnology and decentralized science (DeSci). By allowing global participation, it enables patients, scientists, and investors to collaboratively fund, build, and own tokenized biotech projects and intellectual property (IP). This creates new opportunities for funding and accelerates the progress of life science innovations that have traditionally struggled due to complex funding processes, resource gaps, and fragmented IP ownership.
The protocol addresses key challenges in the biotech space, such as lengthy grant application processes and the "Valley of Death," where promising early-stage discoveries fail to reach commercialization. BIO Protocol leverages decentralized funding, capital efficiency, and shared IP ownership to reduce risks and costs, allowing a more inclusive and global approach to scientific advancement. It also provides liquidity to traditionally illiquid biotech assets, helping bridge the gap between innovative research and market-ready solutions.
At the heart of BIO Protocol is the BIO token, which enables governance and gives holders access to exclusive funding rounds and tokenized IP. The token also facilitates the coordination and support of BioDAOs, ensuring that participants can contribute and benefit from the growth of the ecosystem. BIO Protocol is transforming how biotech research is funded, developed, and shared, fostering a more open, efficient, and innovative environment for the entire industry.